Molecular effects of silicon dioxide nanoparticles on cell survival signaling of Dorsal Root Ganglion (DRG) neurons and schwann cells

Technical Proceedings of the 2011 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2011

Volumn 3, Issue , 2011, Pages 545-548

  Jain, Aditi ^a   Jaiswal, Ashvin R ^a   Lu, Shuangyun ^a   Wong, Yin Yin W ^a   Bhushan, Alok ^a   Leung, Solomon W ^a   Daniels, Christopher K ^a   Lai, James C K ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Cell signaling; Immortalized DRG neurons; Peripheral nervous system; Schwann cells; SiO2 nanotoxicity

Indexed keywords

CELL MODEL; CELL SIGNALING; CELL SURVIVAL; CELL SURVIVAL SIGNALING; DORSAL ROOT GANGLION NEURONS; IN-VITRO; MODEL SYSTEM; MOLECULAR EFFECT; MOLECULAR MECHANISM; NEURAL CELLS; PATHOPHYSIOLOGICAL; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; SCHWANN CELLS; SILICON DIOXIDE NANOPARTICLES; SIO2 NANOTOXICITY;

CELLS; FLUIDICS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NANOTECHNOLOGY; NEURONS; SIGNALING; SILICA; SILICON COMPOUNDS; SILICON OXIDES;

CELL CULTURE;

EID: 81455139773     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (11)

1. "Peripheral Neuropathy Fact Sheet," National institute of Neurological disorders and stroke (NINDS). NIH Publication No. 04-4853.
2. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
3. Riaz SS, Tomlinson DR. 1996. Neurotrophic factors in peripheral neuropathies: pharmacological strategies. Prog Neurobiol 49(2):125-43. (Pubitemid 26253265)
4. Zochodne DW. 1999. Diabetic neuropathies: features and mechanisms. Brain Pathol 9(2):369-91. (Pubitemid 29157722)
5. Purves T et al. 2001. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEBJ 15(13):2508-14. (Pubitemid 33063180)
6. Agthong S et al. 2006. Activation of MAPK/ERK in peripheral nerve after injury.BMC Neurosci 8:7-45.
7. Napierska D. 2010. The nanosilica hazard: another variable entity. Part Fibre Toxicol 3;7(1):39.
8. Sayes CM et al. 2007. Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97:163-180. (Pubitemid 47072165)
9. Lai JC et al. 2010. Treatment of human astrocytoma U87 cells with silicon dioxide nanoparticles lowers their survival and alters their expression of mitochondrial and cell signaling proteins. Int J Nanomed 5:715-23.
10. Puli S et al. 2006. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones. J Neurooncol 79(2): 135-42. (Pubitemid 44349940)
11. Jaiswal AR, Bhushan A, Daniels CK, et al. 2010. A cell culture model for diabetic neuropathy studies. Journal of the Idaho Academy of Science 46(1):58-63.